Reading (United Kingdom of Great Britain & Northern Ireland)
Membership:
HFA Member
Follow
Contributor content
Presentation
GenePHIT phase 2 study design: a double blind, placebo-controlled trial to assess efficacy, safety, and tolerability of AB-1002 gene therapy in adults with heart failure
